Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BL.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.11.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.48NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JQ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.10.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BL.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BL.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CC.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BZ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CK.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.34NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.35NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAY.2.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CH.1.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.36NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BV.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.33NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CP.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.45NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.5.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.41NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.75.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CR.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DV.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BT.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FS.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.54NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
N.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.1.15 (Gamma)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.348NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.575NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Q.4 (Alpha)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.442NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used